published clinical trials of physical therapy for CP.
Cerebral palsy is defined as a group of non-progressive disorders occurring in young children in which diseae of the brain causes impairment of a motor function. The impairment of motor function may be the result of paresis, involuntary movement or incoordination, but motor disorders which are transient or are the result of progressive disease of the brain or attributable to abnormalities of the spinal cord are excluded.6(1~') Most clinicians would agree with Bax's observation that CP is a "not necessarily unchanging" disorder,' despite the apparently static nature of the underlying central nen70us system impairment. Change in the clinical picture over time is probably a function of CNS development, the evolution of motor patterns at reflex and volitional levels, motor learning, and therapy. As a result, the clinical manifestations and motor behaviors of individuals with CP often change and evolve, particularly in children during the first several years of life. Although the neurophysiological basis of CP has been the subject of much study,"" at a clinical level descriptive or evaluative measures of observed motor function can be undertaken, regardless of one's theory of the pathophysiology of CP, using the observed behavior as the "raw material" for the measurement instrument.
General Issues in Measurement
Kirshner and Guyatt have provided a methodological framework for assessing health measures.12 They point out that these measures may be used for one purpose or for various purposes. A discriminative index distinguishes between individuals with and without a particular characteristic or function (eg, the Peabody Developmental Motor Scales13 are used to categorize children via percentile rank scores, standard scores, or age-equivalent scores). Apredzctiie index classifies people into categories based on what is believed or expected will be their future status (eg, the Bleck scale14 predicts ambulation at age 7 years on the basis of a preschool child's postural and tonic reflex activity). An evaluative index is used to measure the magnitude of change in function over time or after treatment (eg, the measure used by Wright and Nicholson15 assessed several motorrelated clinical functions before and after a period of physical therapy). Construction and validation of a measure must be predicated upon its ultimate purpose, and methodological rigor is essential from the initial conception of the measure to the completion of its development and testing.
Note that measures generally are developed and validated specifically to fulfill one of the functions described above. A measure cannot automatically be used for a purpose other than the one for which it was created or applied to a population dissimilar to that on which it was developed and validated. It should be self-evident that Bleck1s'4 predictive measure will not suffice as a discriminative instrument. Bleck's explicit purpose was to develop a test to predict future ambulation based on the presence or absence of seven postural and reflex items, and the scale has excellent measurement properties to accomplish this task (sensitivity = .98; specificity = .%). Seven items, however, would scarcely be adequate to distinguish or discriminate a population of children with CP into anything other than very crude and probably clinically meaningless categories, because the scope and subtlety of motor behavior in this population require much finer distinctions than can be achieved with such a small subsample of the domain of motor function. Similarly, as an evaluative measure, the Bleck scale is limited both in the number of items potentially responsive to change in motor function with time and treatment and in the narrow range of response options (present-absent) by which to annotate improved motor function.
The Peabody Developmental Motor Scales were designed specifically to enable clinicians and others to determine the relative developmental skill level of a child, identify skills that were not completely developed or not in the child's repertoire, and then plan an instructional program to develop those s k i l l s .~~~~)
The large number of items and the three-level response options make it suitable for this purpose, and validation studies have established its usefulness.13 This measure might be valuable as either an evaluative or a predictive motor function measure, but to our knowledge it has not yet been validated for either of these functions.
Creation and Validation of an Evaluative Measure
To assess the clinical motor function outcome of interventions for children with CP, an evaluative measure with specific structural characteristics is required. Items in the measure must be selected on the basis of both clinical releuance and potential responsiveness to change. For example, a therapist might reasonably anticipate a change in duration of independent standing following a physical therapy program, but he or she would be less likely to expect a change in the asymmetric tonic neck reflex (ATNR). It would be appropriate, therefore, to include duration of standing but not ATNR in an evaluative measure, despite the clinical importance of both to overall motor behavior. If the ATNR is indeed not responsive to change, its presence in the evaluative measure serves no purpose and can add error to the instrument. The measure must be feasible to use, with clearly described response options and explicit scaling. The measure must be reliable; that is, it must give consistent responses or scores when used repeatedly with "stable" subjects. The measure must be valid, that is, responsive to real change and stable in the absence of change. The essential component in validating an evaluative instrument is to establish its responsiveness to change.
Any evaluative motor assessment instrument used to measure outcome Physical Theral ~yNolume 70, Number 2February 19N in chi1drc.n with CP must be capable of detecting change in individual children. Responsiveness can be enhanced by one or both of two strategies. First, by increasing the number of responsive items and eliminating those that are unresponsive, the therapist increases the chance that change will be detected if it is actually occurring. Second, by offering several response options for partial as well as complete: accomplishment of each item, there is an increased potential to identify finer gradations of change than is possible with a simple presentabsent response choice.
The reliability and validity of a responsive measure should be established before a measure is used. Reliability refers to the ability of a measure to give consistent responses on repeated assessments in the absence of change in the characteristic being eval~ated.~"otential sources of variability that contribute to unreliability of an inclex include those attributable to obseriers, subjects, environments, timing, and the index itself. These potential sources of variability should be quantified and controlled as fully as possible.
Validity refers to the appropriateness (truth) of inferences made when interpreting a measure, a score, or the results of a test." Several components of validity have been described, including criterion, content, and construct validity.Is Readers are referred to standard textbooks on research methodology such as Principles of Medical Statistics: A Short Textbook of Medical Statistics by Bradford Hil119 for a more complete discussion of these measurement concepts.
In summary, an evaluative measure must contain relevant items and must be applicable to the population for whom it is developed, feasible to use, reliable, and valid for that purpose. The most essential feature of an evaluative measure, however, is its responsiveness to clinically important change over tim,e. Ideally, the therapist should "titrate" the measure by using it to assess change in individuals known to be susceptible to treatments of proven efficacy. Guyatt et al, for example, were able to evaluate the responsiveness of a new functional status measure in patients with chronic lung disease before and after a therapeutic intervention thought likely to produce improvement and to compare that amount of (real) change with the relatively much smaller variability in stable subjects tested repeatedly with the same measure but not receiving any treatment.]
As Meenan et a1 point out, however, When a relatively new outcome measure is used in a situation where the effectiveness of the treatment is unknown, it is difficult to determine whether the findings, be they positive or negative, are due primarily to the properties of the treatment or the properties of the measurement approach.2(~'351)
This uncertainty pervades most areas of developmental medicine, where few, if any, treatments are proven to be eficacious and hence are not useful as "proven interventions" to be used with newly developed measures. Furthermore, none of the available measures of motor function have been validated for their capacity to detect change. We will return to this point in our review of measures used in published clinical trials of physical therapy interventions for children with CP.
Assessing Responsiveness in Absence of a "Goid Standard"
If change cannot be measured because of the absence of measures of known responsiveness, and if no current interventions are of proven value, how can any measure-new or established-be shown to be responsive to clinically important change? Several approaches have been applied, mainly in the area of adult medicine, and these methods, with appropriate adaptations, are relevant to the field of developmental pediatrics.
Meenan et a1 correlated functional score changes on a newly applied clinical measure with changes in physiological function to evaluate the responsiveness of the new m e a s~r e .~ Even though they had the advantage of using a treatment of known efficacy (eg, gold therapy for rheumatoid arthritis), the concurrent changes on the functional, physiological, and clinical indexes provided evidence for the responsiveness of the clinical health status measure.
Deyo and Inui suggested that, in the absence of a "gold standard" for determining what constitutes a clinically important change, the independent, concurrent agreement about change by patient and physician can serve as a basis for defining the presence and magnitude of functionally important changes.3 Using this clinically defined change criterion, they then assessed and contrasted several clinical methods of rating change among people for whom there was agreement that change had actually occurred.
Deyo and Centor argued that there was an analogy between assessing the responsiveness of a functional scale and determining the discriminating properties of a diagnostic test using sensitivity and specificity.4 They created receiver operating characteristic (ROC) curves on which they plotted on the ordinate the true positive rate (sensitivity) of the measure to detect "clinically important change" against the false positive rate (1 -specificity) on the abscissa. Visually, the ROC curve is plotted from the lower left to the upper right of a standard X-Y plot. The curve rises more or less steeply above the 45-degree diagonal, curving to the right and gradually flattening out at the extreme right end. A perfect test, therefore, would be represented by a vertical line along the ordinate, with no horizontal component, whereas a useless test would have a response "curve" along the diagonal at 45 degrees20
Using data from several related measures of change in patients with low back pain, with an improvement criterion of "return to full activity," Deyo and Centor were able to demonstrate the value of short, disease-specific indexes over longer, more general functional scales.4 They suggest, as Kirshner and Guyatt12 have stated, that the removal of unresponsive items from an evaluative measure appears to increase its responsiveness. A second important value of the ROC-curve approach is the capacity to choose a cutoff point of clinical change that best discriminates improved from unimproved patients.
Guyatt et a1 recommend a new statistically based index of responsiveness for clinical measures designed to detect change.' In their approach, issues pertinent to establishing responsiveness are 1) the variability of change scores in subjects considered stable and 2) the amount of change considered to be clinically important. The tirst issue is related to the testretest reliability of the measure; the second issue concerns the validity of the measure, specifically its ability to detect clinically important change in function when that change is believed to have taken place. Statistically, responsiveness is derived by the ratio of the clinically important difference (delta) to the variability in stable subjects (square root of twice the mean square error). Their article contains data-based evidence to support this technique, and they illustrate the utility of this method for sample-size calculation.
The notion of construct z~alzdity18 posits that one puts forward a priori hypotheses about how a measure should perform if it is doing the task for which it was created. In the absence of either a criterion measure against which to compare a new measure or a treatment of known efficacy by which to titrate the new scale, this indirect approach attempts to aggregate data in support of the measure. CP.21 They hypothesized 1) that if the measure were responsive, it should be capable of detecting change in children judged by their parents and therapists to have changed; 2) that children with "mild" CP should show more change per unit of time than age-matched children with "severe" CP; 3) that younger children with CP should change more than older children in the same time period; and 4) that children recovering from acute head injury should show more change than children with CP. Each of these hypotheses has clinical face validity, and each provided a basis for assessing the responsiveness of our new measure (ie, for testing the performance of the measure as an evaluative instrument).
Results of a validation study to establish the responsiveness of the Gross Motor Function Measure (GMFM) have been published elsewhere.21 Briefly, the GMFM assesses 88 items of motor function in five areas: 1) lying and rolling; 2) crawling and kneeling; 3) sitting; 4) standing; and 5) walking, running, and jumping. The GMFM items were derived from several published sources (notably reports by Hoskins and Squires22 and Steel and Spaso@) and organized by body position to allow for ease of testing. All items would usually be accomplished by a 5-year-old with normal motor abilities. Items are scored using a four-point scale (0 = cannot initiate task, 1 = initiates task, 2 = partially completes task, and 3 = completes task), each task being explicitly described in a manual.* In addition to a total score, scores can be calculated for each of the five dimensions described above.
What makes this measure different from other (discriminative) measures such as the Peabody Developmental Motor Scales13 and the Bayley Motor Scale24 is the validation process by which its responsiveness to change was established. The scale was applied to 140 children of various :velopmental Clinical Research Unit ages with a wide range of neuromotor disabilities and to 30 healthy preschool-aged children on two occasions separated by a three-to sixmonth interval. Concurrently, judgments about motor function were made independently by the disabled children's parents and physical therapists. After the second administration of the GMFM, parents and therapists independently made structured judgments about the direction and amount of change in motor function of each child. These judgments of change correlated strongly with GMFM change scores, in support of the hypotheses outlined previously, thus establishing the responsiveness of the GMFM.
In a variation of construct validity, Lipsey recommends the use of criterion groups whose function can be measured and compared to define a "clinically relevant" effect size.5 He suggests that the groups chosen should differ at least as much as the minimal therapeutic effect expected by a intervention. For example, if a therapeutic program were designed to produce one grade year of improvement, criterion groups might be children in grades 3 and 4, with the achievement difference between them representing the effect size to be sought by the therapeutic intervention. The choice of criterion g r o u p s and a criterion ddference so d e f i n e k n a b l e s any measured effects of an intervention to be put into perspective. Lipsey's arguments are complex and largely statistical, but the ideas are clearly presented.5
To determine what respondents considered a "clinically important" effect size, Russell and colleagues asked both the therapists and parents independently to make judgments about the importance of any changes in function they reported at the time of reassessment of each child with the GMFM.2' This approach allowed the authors to detect a gradient of perceived importance with gradations of measured functional change. However, only with continued use of the measure, under varied conditions, will it be possible to refine our understanding of what actually constitutes clinical importance.
In summary, a variety of clinical, psychometric, and statistical approaches for the assessment of responsiveness of clinical measures has been formulated. Combinations of these techniques will generally be required to establish that the measure is responsive to clinically important change in function. Like validity, responsiveness is an abstract property established incrementally over time by the accumulatior1 of evidence about the performance of a measure.
Review of Measures Used in Outcome Studies
We critically reviewed the measures used in published controlled clinical trials of physical therapy interventions for children with CP to highlight the limitations of currently available instruments. Keview articles by Parette and Hourcade25 and Ottenbacher et a12hnd a survey of the recent developmental pediatric literature provided source papers for this analysis. Studies such as those of Goodman et alL7 and Piper et al2Qvaluating therapy for at-risk infants were excluded because those studies used discriminative measures to assess the effectiveness of interventions. (They did not measure the same functions before and after an interfention, for which an evaluative measure is required, but instead undertook postintervention assessments of groups of infants is an effort to discover whether treatment and control ,groups differed on motor function outcomes of interest [a discriminative task].)
The assessment scheme used by Wright and Nicholson15 was largely based on Holt's work." Three dimensions were studied: motor function, range of motion of selected joints, and presence or absence of primary automatic reflexes. The items appear applicable to children with CP up to 6 years of age. They presented no justification concerning the selection of this group of items, apart from the assumption that they "were those common to the normal developmental pattern for l o~o m o t i o n . "~5 ( p~~~ Although a scoring system is presented, the authors did not state whether they used a manual to define the items to provide clarity for an observer required to make such judgments. No evidence is given of the interrater or intrarater reliability.
The validity of the functional component of Wright and Nicholson's15 measure and its value as a discriminative instrument are suggested by the low initial mean scores of the youngest infants (reflecting both young age and severity of CP). They presented no evidence, however, that the measure was capable of detecting change in function, ROM, or reflex patterns in children with CP. The lack of differential change in the treatment group may reflect either lack of efficacy of the treatment or a failure of the measure to detect clinically important change. In the absence of proper validation of the measure for responsiveness to change, one simply cannot tell.
The Bayley Motor Scale24 was used by Carlsenso and Palmer et a131 to evaluate change in motor function. The Bayley Motor Scale has been extensively developed for use as a discriminative measure with infants and very young children, and Bayley herself points out that the scales "have limited value as predictors of later abilities."24(~4) More significantly, she writes that because of rapidly changing development in infancy, "measurement procedures must differ in significant ways for infants only a few months apart in age."24(p5) No responsiveness data are presented to establish the Bayley Motor Scale as an evaluative instrument.
Carlsen3O also used the Denver Developmental Screening Test, which was created as a discriminative screening instrument.32 Motor scale items should be a highly selective subsample of motor functions, designed to differentiate children into those judged to be developing normally, those whose motor function is suspect, and those with impaired motor development. Although the measure is developmental in structure, there is no evidence that it is responsive to clinically important changes in motor function in children with CP. The measure offers neither detailed discriminative nor evaluative functions and has not been demonstrated to be useful as an outcome measure in clinical trials.
Scherzer et a1 used a measure especially constructed for their study but not described in their report. 33 Their measure "indicates change in relation to position, tone, movement and overall function" and was used to evaluate motor outcome. No measurement properties of the instrument are provided to attest to its applicability, feasibility of use, reliability, or validity. In particular, there is no discussion of evidence that the measure is capable of detecting change in motor function if that change actually exists. Overall judgments are made of "definite improvement" or "no improvement," but the basis of these judgments is not explained. On the basis of the evidence presented, one cannot be confident that the measure can detect change in motor function.
Sommerfeld et a134 used measures of reflexes?5 a gross motor assessment compiled by one of the authors from the developmental literature, and goniometric measurements of selected joints. The reflex and goniometric measurements were made according to published methods for testing and recording, but no evidence is presented that the motor function items were applied in a standardized manner. The investigators pretested their measures for test-retest reliability over a two-week period (r = .37-.99). They then selected only those items from the assessment instruments with acceptable evidence of reliability (r = >.70). Choosing only highly reliable (ie, stable) items, however, may decrease the chance of demonstrating the measure's responsiveness.
Sommerfeld et als*.presented no discussion or evidence that any of these measures is responsive to change over time. As with the previous stud-ies, the absence of change in any of the treatment (or control) groups may reflect the lack of responsiveness of the measures.
Hertoti measured stride length, stride width, foot angle, and footprint clarity using an ink-print ambulation pattern on paper.'"he was able to evaluate changes in those variables in children treated with short-leg casting, but it is instructive to quote from the discussion of her article:
I believe t h e measure chosen in this study yielded valuable information o n ambulation changes comparing casted and uncasted children with CP. Subjectively, the therapists involved in this study observed additional proximal changes exhibited by the msted children that could not be documented @ t /~k measure [our emphasis]. These changes were judged to b e significant clinically a n d included improvements in trunk control a n d mobility of the pelvis in positions such as side lying, sitting, and quadruped. Trunk control appeared to b e improved. . . . A followup study using this ambulation measure and an additional measure studying the pelvis o r trunk probably would yield valuable information.'6'~152R) Bertoti 
